Group One Trading’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.56M Sell
470,200
-184,800
-28% -$1.04M ﹤0.01% 1852
2025
Q4
$4.58M Sell
655,000
-143,300
-18% -$1.12M 0.01% 1583
2025
Q3
$6.17M Buy
798,300
+160,700
+25% +$1.25M 0.01% 1303
2025
Q2
$5.55M Sell
637,600
-475,000
-43% -$3.44M 0.01% 1246
2025
Q1
$8.86M Buy
1,112,600
+958,800
+623% +$9.7M 0.03% 694
2024
Q4
$1.4M Buy
153,800
+40,900
+36% +$395K ﹤0.01% 2239
2024
Q3
$1.04M Buy
112,900
+18,800
+20% +$156K ﹤0.01% 2259
2024
Q2
$920K Sell
94,100
-32,900
-26% -$401K ﹤0.01% 2056
2024
Q1
$1.92M Sell
127,000
-346,500
-73% -$6.29M 0.01% 1506
2023
Q4
$10.2M Buy
473,500
+110,500
+30% +$2.04M 0.03% 698
2023
Q3
$6.75M Buy
363,000
+1,000
+0.3% +$23.3K 0.02% 745
2023
Q2
$9.17M Sell
362,000
-70,300
-16% -$1.77M 0.03% 556
2023
Q1
$11.2M Sell
432,300
-704,800
-62% -$18.9M 0.04% 416
2022
Q4
$26.9M Sell
1,137,100
-363,300
-24% -$9.8M 0.06% 311
2022
Q3
$38M Sell
1,500,400
-12,400
-0.8% -$435K 0.07% 183
2022
Q2
$50.2M Sell
1,512,800
-330,100
-18% -$14M 0.08% 198
2022
Q1
$133M Sell
1,842,900
-867,700
-32% -$62.5M 0.13% 84
2021
Q4
$249M Buy
2,710,600
+143,900
+6% +$17.2M 0.2% 51
2021
Q3
$325M Buy
2,566,700
+1,012,900
+65% +$147M 0.35% 34
2021
Q2
$258M Buy
1,553,800
+1,264,700
+437% +$205M 0.31% 33
2021
Q1
$52.5M Sell
289,100
-192,200
-40% -$44.6M 0.08% 197
2020
Q4
$96.2M Buy
481,300
+190,300
+65% +$38.7M 0.17% 69
2020
Q3
$63.8M Buy
291,000
+24,900
+9% +$5.27M 0.2% 70
2020
Q2
$50.8M Sell
266,100
-89,600
-25% -$15.7M 0.23% 63
2020
Q1
$55.1M Buy
355,700
+110,400
+45% +$12.8M 0.45% 27
2019
Q4
$20.5M Buy
245,300
+151,200
+161% +$11.5M 0.14% 140
2019
Q3
$6.37M Buy
94,100
+46,100
+96% +$3.03M 0.05% 454
2019
Q2
$3.19M Buy
48,000
+2,300
+5% +$134K 0.03% 780
2019
Q1
$2.54M Sell
45,700
-37,300
-45% -$2.28M 0.03% 772
2018
Q4
$4.11M Buy
83,000
+38,400
+86% +$2.35M 0.04% 609
2018
Q3
$3.85M Buy
44,600
+11,500
+35% +$820K 0.03% 728
2018
Q2
$1.92M Buy
33,100
+13,400
+68% +$654K 0.02% 1171
2018
Q1
$794K Sell
19,700
-55,300
-74% -$2.09M 0.01% 1685
2017
Q4
$2.61M Buy
75,000
+32,800
+78% +$1.09M 0.02% 1033
2017
Q3
$1.4M Buy
42,200
+7,100
+20% +$233K 0.01% 1325
2017
Q2
$1.22M Sell
35,100
-7,600
-18% -$221K 0.01% 1302
2017
Q1
$1.07M Buy
+42,700
New +$888K 0.01% 1300
2016
Q4
Sell
-5,900
Closed -$108K 4839
2016
Q3
$108K Sell
5,900
-1,700
-22% -$29.8K ﹤0.01% 2880
2016
Q2
$122K Buy
+7,600
New +$88.7K ﹤0.01% 2729

Other funds holding TDOC

Group One Trading's TDOC Position: Q1 2026 in Review

Group One Trading increased its Teladoc Health (TDOC) stake by 40% in Q1 2026, buying an estimated $340K and bringing the position to 212,759 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2574.

Group One Trading first reported a position in TDOC in Q3 2017 and has held it in 26 quarters since. The position peaked at $54M in Q1 2021. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Group One Trading held 212,759 shares of Teladoc Health worth $1.16M as of Q1 2026.
  • Group One Trading bought 60,560 Teladoc Health shares in Q1 2026, an estimated $340K.
  • Teladoc Health made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2574 holding.
  • Group One Trading first reported a position in Teladoc Health in Q3 2017 and has held it in 26 quarters since.
  • Group One Trading's Teladoc Health position peaked at $54M in Q1 2021.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.